文献速递小儿耳鼻咽喉睡眠呼吸障碍

过敏性打鼾与非过敏性打鼾儿童扁桃体增生淋巴细胞中半胱氨酰白三烯受体1和2的表达比较

Expression of cysteinyl leukotriene receptor 1 and 2 (CysLTR1 and CysLTR2) in the lymphocytes of hyperplastic tonsils: comparison between allergic and nonallergic snoring children.
PubMed 文献 · Int Forum Allergy Rhinol · 2016-05-25

研究比较了60例5至10岁因腺样体扁桃体切除术就诊的打鼾儿童中,皮肤点刺试验阳性(致敏组)与阴性(对照组)者扁桃体增生组织中B细胞和T细胞上CysLTR1和CysLTR2的表达。致敏组多个淋巴细胞亚群的CysLTR表达降低,CysLTR2在多数细胞群中表达高于CysLTR1,两组间mRNA表达无显著差异。结论认为CysLTR在非致敏儿童淋巴细胞中表达更高,呼吸道过敏似乎不是扁桃体增生的刺激因素,能同时阻断两种受体的新药值得进一步研究。

要点

  • 致敏组小淋巴细胞中CD3+/CysLTR1+表达降低(4.6±2.2 vs 6.5±5.0,p=0.04)。
  • 致敏组大淋巴细胞中CD3+/CysLTR1+、CD19+/CysLTR1+、CD19+/CysLTR2+表达均降低。
  • 多数细胞群中CysLTR2表达显著高于CysLTR1(p<0.05),两组mRNA表达无显著差异。

核心结论

  • CysLTR在非致敏打鼾儿童扁桃体增生淋巴细胞的表达高于致敏儿童,CysLTR2表达高于CysLTR1。
  • 呼吸道过敏似乎不是扁桃体增生发生的刺激因素。
  • 作者认为能同时阻断两种CysLTR的新药值得进一步研究。

研究设计与样本

  • 研究纳入60例5至10岁因腺样体扁桃体切除术就诊的打鼾儿童,按皮肤点刺试验反应分为致敏组(SE)和对照组(NS)。
  • 对切除组织中的细胞进行CysLTR1、CysLTR2、CD19和CD3染色,并通过流式细胞术计数。
  • 采用实时定量逆转录聚合酶链反应(RT-qPCR)检测CysLTRs基因的信使RNA(mRNA)表达。

主要发现

  • 致敏组小淋巴细胞中CD3+/CysLTR1+表达降低(4.6±2.2 vs 6.5±5.0;p=0.04)。
  • 致敏组大淋巴细胞中CD3+/CysLTR1+表达降低(40.9±14.5 vs 47.6±11.7;p=0.05),CD19+/CysLTR1+表达降低(44.6±16.9 vs 54.1±12.4;p=0.01),CD19+/CysLTR2+表达降低(55.3±11.3 vs 61.5±12.6;p=0.05)。
  • 按淋巴细胞总数计,致敏组CD3+/CysLTR1+淋巴细胞较少(11.1±5.5 vs 13.7±6.2;p=0.04)。
  • 其余所有细胞群在致敏组中表达降低但无统计学显著性。
  • 多数所研究细胞群中CysLTR2表达显著高于CysLTR1(p<0.05),两组间mRNA表达无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cysteinyl leukotriene receptor 1 and 2 (CysLTR1 and CysLTR2) are involved in allergic processes and play a role in adenotonsillar hyperplasia (AH). Clinically, only CysLTR1 may be blocked by montelukast. Our objective was to compare the expression of CysLTR1 and CysLTR2 in the B and T cells of hyperplasic tonsils of sensitized (SE) and control (NS) snoring children. METHODS: Sixty children, 5 to 10 years of age, referred for adenotonsillectomy, were divided into SE and NS groups, according to their responses to the skin-prick test. Cells from the removed tissues were stained for CysLTR1, CysLTR2, CD19, and CD3 and counted via flow cytometry. messenger RNA (mRNA) expression of the CysLTRs genes was measured real-time quantitative reverse transcription polymerase chain reaction (RT-qPCR). RESULTS: The SE group showed reduced expression of the small CD3+/CysLTR1+ lymphocytes (4.6 ± 2.2 vs 6.5 ± 5.0; p = 0.04). Regarding the large lymphocytes, the SE group showed lower expression of CD3+/CysLTR1+ (40.9 ± 14.5 vs 47.6 ± 11.7; p = 0.05), CD19+/CysLTR1+ (44.6 ± 16.9 vs 54.1 ± 12.4; p = 0.01), and CD19+/CysLTR2+ (55.3 ± 11.3 vs 61.5 ± 12.6; p = 0.05) lymphocytes. Considering the total number of lymphocytes, the SE group had fewer CD3+/CysLTR1+ lymphocytes (11.1 ± 5.5 vs 13.7 ± 6.2; p = 0.04). All other cell populations exhibited reduced expression in the SE group without statistical significance. The expression of CysLTR2 was significantly higher (p < 0.05) than CysLTR1 in most studied cell populations. The mRNA expression did not show significant differences between the groups. CONCLUSION: The expression of CysLTR is higher in the lymphocytes of the NS children, and CysLTR2 shows greater expression than CysLTR1 Respiratory allergies do not appear to be a stimulus for AH occurrence. Newer drugs capable of blocking both CysLTRs warrant further study.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Paulucci BP, Pereira J, Picciarelli P, et al. Expression of cysteinyl leukotriene receptor 1 and 2 (CysLTR1 and CysLTR2) in the lymphocytes of hyperplastic tonsils: comparison between allergic and nonallergic snoring children. Int Forum Allergy Rhinol. 2016. PMID: 27221082. doi:10.1002/alr.21798

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。